Fast and Chronic Programmes, Alexandra Hospital, Queenstown, Singapore.
Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
J Nephrol. 2024 May;37(4):841-850. doi: 10.1007/s40620-023-01835-1. Epub 2024 Jan 5.
The number of patients aged > 75-years treated by dialysis continues to increase, particularly in developed countries. Haemodialysis is a well-established treatment with national and international clinical guidelines designed to provide patients with optimal treatment. However, these were developed when the dialysis population was younger, and less co-morbid. This change in patient demographics questions whether these guideline targets still apply to older patients. More patients now start dialysis with residual kidney function and could benefit from a less frequent dialysis schedule. Older patients have a lower thirst drive, so lower interdialytic gains, reduced appetite, muscle mass and physical activity would potentially allow starting dialysis with less frequent sessions a practical option. Similarly, patients with residual kidney function and lower metabolic activity may not need to meet current dialyser Kt/Vurea clearance targets to remain healthy. Instead, some elderly patients may be at risk of malnutrition and might need liberalisation of the low salt, potassium and phosphate dietary restrictions, or even additional supplements to ensure adequate protein intake. Although a fistula is the preferred vascular access, a forearm fistula may not be an option due to vascular disease, while a brachial fistula can potentially compromise cardiovascular reserve, so a dialysis catheter becomes the de facto access, especially in patients with limited life expectancy. Thus, clinical guideline targets designed for a younger less co-morbid dialysis population may not be equally applicable to the older patient initiating dialysis, and so a more individualised approach to dialysis prescription and vascular access is required.
接受透析治疗的年龄>75 岁的患者人数持续增加,尤其是在发达国家。血液透析是一种成熟的治疗方法,有国家和国际临床指南旨在为患者提供最佳治疗。然而,这些指南是在透析人群更年轻、合并症更少的情况下制定的。患者人口统计学的这种变化质疑这些指南目标是否仍然适用于老年患者。现在更多的患者开始透析时仍有残余肾功能,并且可以从更不频繁的透析方案中受益。老年患者口渴感较低,因此更少的透析间期体重增加、食欲下降、肌肉量减少和体力活动可能使更频繁的透析方案成为一种可行的选择。同样,有残余肾功能和较低代谢活性的患者可能不需要满足当前透析器 Kt/Vurea 清除率目标来保持健康。相反,一些老年患者可能存在营养不良的风险,可能需要放宽低盐、低钾和低磷饮食限制,甚至需要额外的补充剂来确保足够的蛋白质摄入。尽管瘘管是首选的血管通路,但由于血管疾病,前臂瘘管可能不是一种选择,而肱动脉瘘管可能会损害心血管储备,因此透析导管成为事实上的通路,尤其是在预期寿命有限的患者中。因此,为年轻、合并症较少的透析人群设计的临床指南目标可能并不完全适用于开始透析的老年患者,因此需要对透析处方和血管通路采取更个体化的方法。